Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Non-steroidal Anti-inflammatory Drugs (NSAID) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-steroidal Anti-inflammatory Drugs (NSAID) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Human accounting for % of the Non-steroidal Anti-inflammatory Drugs (NSAID) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Salicylates segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, and Elanco, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-steroidal Anti-inflammatory Drugs (NSAID) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Non-steroidal Anti-inflammatory Drugs (NSAID) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), with price, sales, revenue and global market share of Non-steroidal Anti-inflammatory Drugs (NSAID) from 2019 to 2022.
Chapter 3, the Non-steroidal Anti-inflammatory Drugs (NSAID) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-steroidal Anti-inflammatory Drugs (NSAID) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-steroidal Anti-inflammatory Drugs (NSAID) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-steroidal Anti-inflammatory Drugs (NSAID).
Chapter 13, 14, and 15, to describe Non-steroidal Anti-inflammatory Drugs (NSAID) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-steroidal Anti-inflammatory Drugs (NSAID) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Human accounting for % of the Non-steroidal Anti-inflammatory Drugs (NSAID) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Salicylates segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, and Elanco, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-steroidal Anti-inflammatory Drugs (NSAID) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Salicylates
- Propionic acid derivatives
- Acetic acid derivatives
- Enolic acid (Oxicam) derivatives
- Anthranilic acid derivatives (Fenamates)
- Selective COX-2 inhibitors (Coxibs)
- Sulfonanilides
- Human
- Animals
- Others
- Bayer
- Ecotrin
- Generic
- St. Joseph
- Elanco
- Zoetis
- Boehringer Ingelheim
- Merial
- Merck Animal Health
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-steroidal Anti-inflammatory Drugs (NSAID) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), with price, sales, revenue and global market share of Non-steroidal Anti-inflammatory Drugs (NSAID) from 2019 to 2022.
Chapter 3, the Non-steroidal Anti-inflammatory Drugs (NSAID) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-steroidal Anti-inflammatory Drugs (NSAID) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-steroidal Anti-inflammatory Drugs (NSAID) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-steroidal Anti-inflammatory Drugs (NSAID).
Chapter 13, 14, and 15, to describe Non-steroidal Anti-inflammatory Drugs (NSAID) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size & Forecast
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume (2017-2028)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2028)
1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity Analysis
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Total Production Capacity (2017-2028)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
1.6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
1.6.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ecotrin
2.2.1 Ecotrin Details
2.2.2 Ecotrin Major Business
2.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Generic
2.3.1 Generic Details
2.3.2 Generic Major Business
2.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 St. Joseph
2.4.1 St. Joseph Details
2.4.2 St. Joseph Major Business
2.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merial
2.8.1 Merial Details
2.8.2 Merial Major Business
2.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Merck Animal Health
2.9.1 Merck Animal Health Details
2.9.2 Merck Animal Health Major Business
2.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) BREAKDOWN DATA BY MANUFACTURER
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-steroidal Anti-inflammatory Drugs (NSAID)
3.4 Market Concentration Rate
3.4.1 Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share in 2021
3.4.2 Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share in 2021
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2017-2028)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.5 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Type (2017-2028)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Application (2017-2028)
6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
6.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
7.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
7.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
7.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
8.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
9.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
10.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
10.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
10.3.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
11.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
11.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Non-steroidal Anti-inflammatory Drugs (NSAID) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-steroidal Anti-inflammatory Drugs (NSAID)
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size & Forecast
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume (2017-2028)
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2028)
1.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity Analysis
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Total Production Capacity (2017-2028)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
1.6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
1.6.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ecotrin
2.2.1 Ecotrin Details
2.2.2 Ecotrin Major Business
2.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Generic
2.3.1 Generic Details
2.3.2 Generic Major Business
2.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 St. Joseph
2.4.1 St. Joseph Details
2.4.2 St. Joseph Major Business
2.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merial
2.8.1 Merial Details
2.8.2 Merial Major Business
2.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Merck Animal Health
2.9.1 Merck Animal Health Details
2.9.2 Merck Animal Health Major Business
2.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
2.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) BREAKDOWN DATA BY MANUFACTURER
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-steroidal Anti-inflammatory Drugs (NSAID)
3.4 Market Concentration Rate
3.4.1 Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share in 2021
3.4.2 Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer Market Share in 2021
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2017-2028)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.5 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Type (2017-2028)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Application (2017-2028)
6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
6.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
7.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
7.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
7.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
8.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
9.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
10.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
10.3 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
10.3.2 South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
11.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
11.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Non-steroidal Anti-inflammatory Drugs (NSAID) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-steroidal Anti-inflammatory Drugs (NSAID)
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 6. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ecotrin Basic Information, Manufacturing Base and Competitors
Table 8. Ecotrin Major Business
Table 9. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 10. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Generic Basic Information, Manufacturing Base and Competitors
Table 12. Generic Major Business
Table 13. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 14. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. St. Joseph Basic Information, Manufacturing Base and Competitors
Table 16. St. Joseph Major Business
Table 17. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 18. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Major Business
Table 21. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 22. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zoetis Basic Information, Manufacturing Base and Competitors
Table 24. Zoetis Major Business
Table 25. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 26. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 30. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merial Basic Information, Manufacturing Base and Competitors
Table 32. Merial Major Business
Table 33. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 34. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Merck Animal Health Major Business
Table 37. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 38. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Non-steroidal Anti-inflammatory Drugs (NSAID), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site of Key Manufacturer
Table 44. Non-steroidal Anti-inflammatory Drugs (NSAID) New Entrant and Capacity Expansion Plans
Table 45. Non-steroidal Anti-inflammatory Drugs (NSAID) Mergers & Acquisitions in the Past Five Years
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 63. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 64. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 67. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 68. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 69. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 70. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 71. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 72. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 75. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 76. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 77. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 86. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 87. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 88. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 91. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 92. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 93. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 102. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Material
Table 103. Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
Table 107. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 6. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ecotrin Basic Information, Manufacturing Base and Competitors
Table 8. Ecotrin Major Business
Table 9. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 10. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Generic Basic Information, Manufacturing Base and Competitors
Table 12. Generic Major Business
Table 13. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 14. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. St. Joseph Basic Information, Manufacturing Base and Competitors
Table 16. St. Joseph Major Business
Table 17. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 18. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Major Business
Table 21. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 22. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zoetis Basic Information, Manufacturing Base and Competitors
Table 24. Zoetis Major Business
Table 25. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 26. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 30. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merial Basic Information, Manufacturing Base and Competitors
Table 32. Merial Major Business
Table 33. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 34. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 36. Merck Animal Health Major Business
Table 37. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Services
Table 38. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Non-steroidal Anti-inflammatory Drugs (NSAID), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Non-steroidal Anti-inflammatory Drugs (NSAID) Production Site of Key Manufacturer
Table 44. Non-steroidal Anti-inflammatory Drugs (NSAID) New Entrant and Capacity Expansion Plans
Table 45. Non-steroidal Anti-inflammatory Drugs (NSAID) Mergers & Acquisitions in the Past Five Years
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 63. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 64. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 67. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 68. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 69. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 70. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 71. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 72. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 75. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 76. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 77. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 86. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 87. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 88. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 91. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 92. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 93. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 102. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Material
Table 103. Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Distributors
Table 107. Non-steroidal Anti-inflammatory Drugs (NSAID) Typical Customers
LIST OF FIGURES
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type in 2021
Figure 3. Salicylates
Figure 4. Propionic acid derivatives
Figure 5. Acetic acid derivatives
Figure 6. Enolic acid (Oxicam) derivatives
Figure 7. Anthranilic acid derivatives (Fenamates)
Figure 8. Selective COX-2 inhibitors (Coxibs)
Figure 9. Sulfonanilides
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application in 2021
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2017-2028) & (K Units)
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2028) & (USD/Unit)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (2017-2028) & (K Units)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Figure 22. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturer in 2021
Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturer in 2021
Figure 25. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 30. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 33. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2028) & (USD/Unit)
Figure 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 44. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 45. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 49. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 52. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 61. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 68. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 69. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 70. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021
Figure 82. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 83. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type in 2021
Figure 3. Salicylates
Figure 4. Propionic acid derivatives
Figure 5. Acetic acid derivatives
Figure 6. Enolic acid (Oxicam) derivatives
Figure 7. Anthranilic acid derivatives (Fenamates)
Figure 8. Selective COX-2 inhibitors (Coxibs)
Figure 9. Sulfonanilides
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application in 2021
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2017-2028) & (K Units)
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2017-2028) & (USD/Unit)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (2017-2028) & (K Units)
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Figure 22. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturer in 2021
Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturer in 2021
Figure 25. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 30. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 33. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (USD Million)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2028) & (USD/Unit)
Figure 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 44. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 45. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 49. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 52. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 61. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 68. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 69. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2017-2028)
Figure 70. South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021
Figure 82. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure 83. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
